InsiderEdge™ – Top Sales and Top Purchases – April 15, 2026

Insider Return Purchases

The insider purchases with the strongest historical return profiles. Remember, returns and win rates are calculated using the previous purchase trades by the insider.

10% Owner at CROSS TIMBERS ROYALTY TRUST ($CRT)

OLIVER ERIC L (10% Owner) purchased 6,844 shares at $10.42/share ($71.31K total), which increased their listed holdings by 0.94%. The current price is $10.52 (+0.96%). This is their 9th largest purchase out of 10 all time. SEC Source

Historic Returns
1m returns: 13.14% weighted | 75% win rate (3/4)
3m returns: 25.57% weighted | 100% win rate (4/4)
6m returns: 56.42% weighted | 100% win rate (4/4)
1y returns: 164.57% weighted | 100% win rate (2/2)

Note: This insider has made 6 total purchases at this company in the last 30 days.

Insider Return Sales

The insider sales with the strongest historical downside performance (positive returns indicate the stock price fell after prior sales). Returns and win rates are calculated using the insider’s previous sell trades.

VP Contactor Business Unit at AEHR TEST SYSTEMS ($AEHR)

SPORCK ALISTAIR N (VP Contactor Business Unit) sold 2,000 shares at $67.36/share ($134.73K total), which decreased their listed holdings by 6.29%. The current price is $73.11 (+8.53%). This is their 1st largest sale out of 8 all time. SEC Source

Historic Returns
1m returns: -11.71% weighted | 43% win rate (3/7)
3m returns: -12.80% weighted | 50% win rate (3/6)
6m returns: -8.86% weighted | 50% win rate (3/6)
1y returns: 43.05% weighted | 80% win rate (4/5)

Note: Selling the rip (stock was up 52.28% in the week before the sale).
Note: 9 insiders have made 10 total sales at this company in the last 30 days.

President and CEO at AEHR TEST SYSTEMS ($AEHR)

Erickson Gayn (President and CEO) sold 152,824 shares at $70.58/share ($10.79M total), which decreased their listed holdings by 28.36%. The current price is $73.11 (+3.58%). This is their 1st largest sale out of 36 all time. SEC Source

Historic Returns
1m returns: 5.26% weighted | 51% win rate (18/35)
3m returns: 4.29% weighted | 57% win rate (20/35)
6m returns: 21.42% weighted | 49% win rate (17/35)
1y returns: 33.91% weighted | 52% win rate (17/33)

Note: Selling the rip (stock was up 52.28% in the week before the sale).
Note: 9 insiders have made 10 total sales at this company in the last 30 days.

Chief Executive Officer at MoonLake Immunotherapeutics ($MLTX)

Santos da Silva Jorge (Chief Executive Officer) sold 150,000 shares at $18.35/share ($2.75M total), which decreased their listed holdings by 4.88%. The current price is $18.75 (+2.19%). This is their 3rd largest sale out of 4 all time. SEC Source

Historic Returns
1m returns: 1.58% weighted | 67% win rate (2/3)
3m returns: 20.83% weighted | 100% win rate (3/3)
6m returns: 7.51% weighted | 100% win rate (3/3)
1y returns: 18.00% weighted | 100% win rate (3/3)

Note: 2 insiders have made 2 total sales at this company in the last 30 days.

Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.